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Summary. Background: Secondary hyperparathyroidism is a common acquired disorder seen in chronic renal 
failure. Its pathophysiology is mainly due to hyperphosphatemia and vitamin D deficiency and resistance. 
When medical treatment fails, subtotal and total parathyroidectomy with autotransplantation are the standard 
procedures, although both are associated with high recurrence rates. Methods and Results: 4 patients experienced 
persistence and 9 relapse. The first 4 were subjected to reoperation after 6 months for the persistence of symp-
toms due to the finding of a supernumerary adenomatous gland while the remaining patients at the reoperation 
showed in 5 cases 2 more glands in over thymic position, and 4 an hyperplasia of the residual glandular tissue. A 
classic cervicotomy was suﬃcient to remove the residual parathyroid in patients with persistent hyperparathy-
roidism. For cases of recurrent hyperparathyroidism it was enough a medial approach and sometimes lateral for 
the complete excision of the hyperplastic tissue. The advent of the intraoperative technique of parathyroid hor-
mone dosage allowed a better performance of the surgical technique for the last 3 patients undergoing reopera-
tion. After reoperation all patients had immediate regression of clinical symptoms with normalization of serum 
calcium and PTH levels. Conclusions: On the basis of these considerations, diagnostic imaging has a not negli-
gible role because during the first intervention helps to have an idea of the possible location of the glands and 
thus to avoid the risk of recurrence and relapse due to ectopic or supernumerary tissue. (www.actabiomedica.it)
Key words: recurrent hyperparathyroidism; persistent hyperparathyroidism; subtotal parathyroidectomy; in-
traoperative parathyroid hormone measurement
Acta Biomed 2017; Vol. 88, N. 3: 325-328 DOI: 10.23750/abm.v%vi%i.4722                   © Mattioli 1885
C a s e  r e p o r t
Introduction
In secondary hyperparathyroidism all the para-
thyroid glands including supernumerary and ectopic, 
in relation to the altered calcium-phosphorus me-
tabolism linked with chronic renal failure, undergo 
hyperplasia and increased production of parathyroid 
hormone (PTH) (1-3). 
This altered metabolism remains even after par-
athyroidectomy and can be associated with supernu-
merary or ectopic glands undetected under first in-
tervention, residue parathyroid tissue left intention-
ally after subtotal parathyroidectomy or accidentally 
(seeding of glandular fragments within surgical breach 
after total parathyroidectomy), the forearm autograft 
(4). All procedures can cause secondary hyperparath-
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yroidism that may persist or recur because of hyper-
function of the parathyroid remnant or transplanted 
parathyroid tissue.
Secondary hyperparathyroidism is called “persis-
tent” when there are high levels of serum calcium and 
parathyroid hormone within 6 months from the first 
cervical exploration, after this period a later occurrence 
of symptoms and signs of secondary hyperparathy-
roidism is called “recurrent” or “relapsed”. In persistent 
secondary hyperparathyroidism the residual tissue is 
widely secreting (adenoma, hyperplasia), while in the 
recurrent forms the interval is related to the progres-
sive hyperplasia or adenomatous degeneration faced 
by the residual tissue. Proportionally the more residual 
glandular tissue is, the lower this period will be (5,6). 
Severe untreated hyperparathyroidism may lead 
to various complications such as calciphylaxis(7-9), 
myelofibrosis (10), cardiovascular diseases and in 
some patients with longstanding secondary hyperpar-
athyroidism after kidney transplant can cause tertiary 
hyperparathyroidism (11). At present surgery is the 
only eﬀective therapeutic strategy for advanced renal 
hyperparathyroidism refractory to medical treatment.
Materials and methods
130 patients underwent subtotal parathyroidecto-
my for symptomatic secondary hyperparathyroidism. 
Among them, 4 cases experienced persistence and 9 
relapse. The 4 patients with persistent hyperparathy-
roidism with dialysis average age of 9 years (range 
1-18 aa) and postintervention levels of parathyroid 
hormone (PTH) > 350 ng/ml were subjected to reop-
eration after 6 months for the persistence of symptoms 
due to the finding of a supernumerary adenomatous 
gland in most cases sunk in the loose above thymic tis-
sue not detected during the first operation. The 9 pa-
tients with recurrent hyperparathyroidism with dialysis 
average age of 7 years (range 1-13 aa) were subjected 
to reoperation, about 5 years after initial subtotal par-
athyroidectomy performed elsewhere, for the appear-
ance of the typical symptoms (asthenia and itch), high 
levels of calcium (>10 mg/dl) and PTH (>400 ng/ml). 
At the reoperation were detected for 5 patients 2 more 
glands in over thymic position, while for the remain-
ing patients it was found an hyperplasia of the residual 
glandular tissue perhaps left too abundant during the 
first intervention. Since 2003 we submitted 70 patients 
to subtotal parathyroidectomy taking advantage of the 
intraoperative dosage of PTH. Of such patients only 
3 were subjected to reoperation 4 years after for the 
return of symptoms accompanied by a modest increase 
in PTH levels (PTH average 527 ng/ml) despite the 
abetement values in the post intervention was around 
70% (mean baseline PTH 1128 ng/ml; I.O. PTH av-
erage 338 ng/ml) compared to baseline.
At the reoperation in one case it was found a su-
pernumerary gland in above thymic position accessible 
with cervicotomy. In the other two cases there was an 
hyperplasia of the residue glandular tissue of the top 
right parathyroid left in the course of first interven-
tion. In all cases we have performed a thorough diag-
nostic study with an ultrasound of the neck, cervical 
and mediastinal CT scan and finally parathyroid scin-
tigraphy with dual tracer and for the last 3 cases also 
total body scintigraphy which allowed us to locate the 
glands in 100% of cases. 
A classic cervicotomy was suﬃcient to remove 
the residual parathyroid in patients with persistent hy-
perparathyroidism. During the first surgery the strap 
muscles were separated along the median line, isolat-
ing later the thyroid lobes by blunt. In reoperation, 
opened the superficial fascial cutaneous plan, following 
the medial border of the sternocleidomastoid muscle, 
was identified the vascular nervous bundle which was 
slightly dislocated laterally to dissect then the strap 
muscles along the groove where adhesions with the 
thyroid capsule are generally minimal. Reached the 
esophageal plane it was reperted the recurrent laryn-
geal nerve with a cautious blunt dissection and once 
isolated it was loaded on elastic strip. Always fol-
lowing the medial border of the sternocleidomastoid 
reached the jugular dimple, it is possible to find the 
thymic tongue in which it was found the supernumer-
ary gland, a gentle upward traction of the thymus on 
Duval’s clamp has enabled a better finding and resec-
tion of the included parathyroid. For cases of recurrent 
hyperparathyroidism it was enough a medial approach 
and sometimes lateral for the complete excision of the 
hyperplastic tissue. 
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Results
A total of 9 cases have showed recurrent hyper-
paratiroidism: 5 related to supernumerary above thym-
ic glands for which it was enough a midline approach 
with complete exeresis of the hyperplastic tissue and 
the remaining 4 with residue hyperplastic glandular 
tissue for which it is performed the way of lateral ap-
proach described previously. The advent of the intra-
operative technique of parathyroid hormone dosage 
allowed a better performance of the surgical technique 
for the last 3 patients undergoing reoperation. In the 
first case the 85% reduction of the levels of parathyroid 
hormone was obtained 10 minutes after the removal 
of the supernumerary gland (baseline PTH 560 ng/
ml; I.O.PTH 84 ng/ml) while in the remaining 2 in-
terventions the reduction of PTH was of 89% after 10 
minutes of the removal of residue glandular tissue of 
the top right parathyroid. (mean baseline PTH 495 
ng/ml; I.O. average PTH  55 ng/ml). After reopera-
tion all patients had immediate regression of clinical 
symptoms with normalization of serum calcium and 
PTH levels.
Conclusions
Very often the real reason of the failure of par-
athyroidectomy is related to the incorrect preoperative 
anthropomorphological evaluation of the areas where 
there may be eventual hyperplastic glands . An excel-
lent embryological knowledge of parathyroid glands 
is crucial to operative success during both initial and 
reoperative parathyroid surgical exploration. 
The superior parathyroid glands are also known 
as parathyroid IVs, because they arise from the dorsal 
wing of the fourth pharyngeal pouch and from here 
migrate along the lateral thyroid sketch. Similarly, the 
inferior parathyroid glands are also known as para-
thyroid IIIs, because they arise from the dorsal part 
of the third pharyngeal pouch, and the thymus arises 
from the ventral part of the third pharyngeal pouch. 
As the inferior parathyroid glands and the thymus mi-
grate together toward the mediastinum, they eventu-
ally separate. In most cases, the inferior parathyroid 
glands become localized near the inferior poles of the 
thyroid, and the thymus continues to migrate toward 
the mediastinum.
Anomalies during the migration process may 
involve variations in the number and location of the 
parathyroid glands, known as “parathyroid ectopias”. 
Arrest of thyroid descent can occur anywhere from the 
tongue down to the lower neck (12,13).
Each factor that can interfere with the embryo-
logical migration of parathyroid glands can determine 
the ectopic location. 
This condition aﬀects more frequently the inferior 
parathyroid glands, whose migration can stop at any 
point of the route from the angle of the mandible to 
the lower pole of the thyroid lobes. Moreover, if dur-
ing the descent there is a close contact or an inclu-
sion inside of the thymic sketch, the parathyroid can 
be dragged up in the anterior mediastinum, within or 
outside thymic location. According to the same mech-
anism, for the close relations in terms of development 
between thymic sketch and primitive heart, it may 
develop a rare parathyroid ectopia intrapericardial or 
intracardiac (14,15).
From these brief embryological premises, it is 
understood as, given the frequency and variability of 
ectopias, there is not a “normal” typical and precise 
allocation for parathyroid glands, especially for the 
lower, but we can speak rather of an “area”where they 
normally localize and of how often the boundaries 
between traditional and ectopic area tend to overlap, 
blending into one another until reaching the position 
frankly ectopic or the rare ectopia. 
The wide range of parathyroid anatomic variations 
may make it diﬃcult to predict a patient’s anatomy 
preoperatively. On the basis of these considerations, 
diagnostic imaging has a not negligible role because 
during the first intervention helps to have an idea of 
the possible location of the glands and thus to avoid 
the risk of recurrence and relapse due to ectopic or su-
pernumerary tissue (16).
It was established that the reasons for failed sur-
gery are due to unrecognized glands in 70% of cases, 
in 15% to ectopic glands, in 15% to supernumerary 
glands. In case of reoperation, moreover, it has proved 
indispensable intraoperative monitoring of PTH to 
evaluate the reduction or the persistence of high hor-
mone levels (17-20) that require searching in all pos-
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sible anatomical sites (even those ectopic): all that is 
meaningless without an accurate preoperative study 
that protects from a possible failure.
Finally, the reoperation can be avoided in more 
than 95% of cases as long as the surgeon has an ex-
cellent knowledge also of parathyroid glands embryol-
ogy in the areas with higher rate of ectopy and above 
all operate a large and meticulous cervical exploration 
also to search possible supernumerary glands. For pa-
tients with relapsed or recurrent disease it is essential 
an accurate preoperative diagnostic study and the use 
of intraoperative parathyroid hormone measurement 
to guarantee total success (21,22). 
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